TORONTO, June 19, 2017 /CNW/ - Horizons ETFs Management (Canada) Inc. has announced that it has undertaken the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ").
HMMJ is the first ETF in the world that offers direct exposure to North American-listed stocks that are involved with marijuana bioengineering and production.
HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index (the "Index"), net of expenses. The Index provides exposure to the performance of a basket of North American publicly listed life sciences companies, and other firms, with significant business activities in the marijuana industry. The Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses related to the marijuana industry.
Rebalancing of the North American Medical Marijuana Index, and by extension, the Horizons Marijuana Life Sciences Index ETF, occurs before the end of each calendar quarter. At that point, all stocks eligible for inclusion in the Index are weighted by their respective market capitalization. However, no single stock can exceed 10% of the weight of the portfolio at the rebalance date.
In conjunction with the recently announced Index rebalance by the Index calculation agent (Solactive AG), HMMJ has also rebalanced the holdings of the ETF portfolio. The latest holdings of the ETF and their current portfolio weights can be accessed at www.HorizonsETFs.com/HMMJ.
It is important to note that HMMJ may not hold all of the constituent names in the Index. HMMJ's manager, through the use of a stratified sampling strategy and consistent with its investment objectives, may invest HMMJ in the securities of issuers that it believes continue to closely match the investment characteristics of the Index, and are consistent with the investment objective and strategy of the ETF. For additional information regarding the investment strategy of HMMJ, investors are encouraged to read the amended and restated prospectus dated June 8, 2017. The amended and restated prospectus is available at www.sedar.com and on the manager's website at www.HorizonsETFs.com/HMMJ.
Horizons ETFs Management (Canada) Inc. and its affiliate AlphaPro Management Inc. are innovative financial services companies offering the Horizons ETFs family of exchange traded funds. The Horizons ETFs family includes a broadly diversified range of investment tools with solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has more than $7.8 billion of assets under management and with 77 ETFs listed on the Toronto Stock Exchange, the Horizons ETFs family makes up one of the largest families of ETFs in Canada. Horizons ETFs Management (Canada) Inc. and AlphaPro Management Inc. are members of the Mirae Asset Global Investments Group.
About Solactive (www.solactive.com)
Solactive AG is an innovative index provider that focuses on the development, calculation and distribution of tailor-made indices over all asset classes. The Company was established in 2007 and is headquartered in Frankfurt, Germany. As of January 2017, Solactive AG served relatively 350 clients in Europe, America and Asia, with approximately USD $100 billion invested in products linked to indices calculated by the Company globally, primarily via 250 exchange traded funds from a number of well-known providers.
Horizons ETFs is a member of Mirae Asset Global Investments. Commissions, management fees, expenses and applicable sales taxes all may be associated with an investment in the Horizons Marijuana Life Sciences Index ETF managed by Horizons ETFs Management (Canada) Inc. (the "ETF"). The ETF is not guaranteed, its value changes frequently and past performance may not be repeated. The Prospectus contains important detailed information about the ETF. Please read the Prospectus before investing.
HMMJ is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade name or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade name for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in HMMJ nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in HMMJ.
SOURCE Horizons ETFs Management (Canada) Inc.
For further information: For investor inquiries: 1-866-641-5739 (toll-free) or (416) 933-5745, [email protected]; For press or other inquiries: Mark Noble, Senior Vice-President and Head of Sales Strategy, Horizons ETFs Management (Canada) Inc., (416) 640-8254, [email protected]